Author:
Zhang Panliang,Wang Wanru,Dai Guilin,Wang Shichuan,Xu Weifeng,Tang Kewen
Funder
National Natural Science Foundation of China
Hunan Provincial Natural Science Foundation of China
Subject
Applied Microbiology and Biotechnology,Biochemistry,Bioengineering
Reference37 articles.
1. Bisoprolol compared with carvedilol and metoprolol succinate in the treatment of patients with chronic heart failure;Frohlich;Clin. Res. Cardiol.,2017
2. A fixed-dose combination of bisoprolol and amlodipine for hypertension: a potential benefit to selected patients;Cohen;Clin. Pharm. Drug Dev.,2017
3. Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial;Williams;Lancet,2015
4. Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension;de Man;Circulation,2012
5. Effects of celiprolol and bisoprolol on blood pressure, vascular stiffness, and baroreflex sensitivity;Eguchi;Am. J. Hypertens.,2015